封面
市場調查報告書
商品編碼
1891207

體外毒性測試市場按類型、最終用戶和地區分類

In Vitro Toxicity Testing Market, By Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年體外毒性測試市場規模預計為 100.4 億美元,預計到 2032 年將達到 243.6 億美元,2025 年至 2032 年的複合年成長率為 13.5%。

報告內容 報告詳情
基準年: 2024 2025年市場規模: 100.4億美元
歷史數據時期: 2020-2024 預測期: 2025-2032
預測期間(2025-2032年): 13.50% 2032 年的預測值: 243.6億美元

目前正在進行研究活動,探索替代傳統動物毒性試驗的方法,例如體外毒性試驗,並輔以電腦模擬(in silico)和化學試管內(in chemico)等方法。代謝、毒代動力學和生物分析研究均以體外毒性試驗服務為支撐。為此,建立體外毒性評估工具至關重要,它能夠提供必要的測試系統和數據,用於開發系統生物學和生理建模等領域的計算建模工具。由於科學有效性、高效性、成本效益和倫理合理性等諸多因素,利用人類細胞和類器官的體外技術在化學品毒性評估中變得越來越受歡迎。

市場動態

市場主要企業正專注於研發,預計這將推動市場在不久的將來成長。例如,2021年6月21日,經合組織測試指南計畫國家協調員工作小組第33次會議(於2021年4月在奧地利舉行)核准了修訂後的《使用魚類細胞株進行急性毒性測試方法的測試指南》,該指南由經合組織動物保護國際理事會(ICAPO)發布。大量研究表明,按照經合組織測試指南執行的該測試方法能夠有效預測多種化學物質對魚類的急性毒性。因此,將此測試方法納入魚類急性毒性評估的證據權重或綜合測試與評估方法(IATA)中,預計將在很大程度上取代魚類急性毒性測試。

本次調查的主要特點

  • 本報告以 2024 年為基準年,對 2025 年至 2032 年的全球體外毒性測試市場進行了詳細分析,並給出了市場規模和複合年成長率。
  • 它還重點介紹了各個細分市場的潛在商機,並為該市場說明了一個有吸引力的投資提案矩陣。
  • 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業。
  • 本報告基於以下幾個方面,對全球體外毒性測試市場的主要參與企業進行了分析:公司概況、產品系列、關鍵亮點、財務表現和策略。
  • 本報告的研究結果將使負責人和經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球體外毒性測試市場報告的目標受眾是該行業的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過全球體外毒性測試市場分析中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章 研究目標與前提條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場範圍

  • 報告概述
    • 市場定義和範圍
  • 執行摘要
  • 一致性機會圖(COM)

第3章:市場動態、監理及趨勢分析

  • 市場動態
    • 促進要素
    • 抑制因素
    • 市場機遇
  • 影響分析
  • 近期產品發布
  • 流行病學
  • 合併、收購和合作
  • 法規環境
  • PEST分析

4. 2020-2032年全球體外毒性測試市場(按類型分類)

  • 概述
  • 吸收
  • 危險物質
  • 行政

5. 2020-2032年全球體外毒性測試市場(依最終用戶分類)

  • 概述
  • 化妝品產業
  • 製藥業
  • 食品工業
  • 化工

6. 2020-2032年全球體外毒性測試市場(按地區分類)

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 中東
    • GCC
    • 以色列
    • 其他中東地區
  • 非洲
    • 北非
    • 中非
    • 南非

第7章 競爭情勢

  • Bio-Rad Laboratories, Inc.
  • Cyprotex
  • Covance Inc.
  • LifeNet Health LifeSciences
  • Creative Bioarray
  • Charles River Laboratories
  • Intertek Group plc
  • LGC Limited
  • SGS Societe Generale de Surveillance SA
  • Preferred Cell Systems
  • Microbac Laboratories, Inc.
  • Eurofins Discovery
  • Creative Biolabs
  • LAUS GmbH
  • Vimta Labs Ltd.

第8章各節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI3855

In Vitro Toxicity Testing Market is estimated to be valued at USD 10.04 Bn in 2025 and is expected to reach USD 24.36 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 10.04 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 13.50% 2032 Value Projection: USD 24.36 Bn

The research activities are conducted to find alternatives to conventional animal-based toxicity testing such as in vitro toxicology assays thatare complemented by in silico and in chemico testing procedures. The metabolic, toxicokinetic, and bioanalytical research is supported by the in vitro toxicity testing services. The establishment of tools for in vitro toxicity assessment, which offers test systems and data required for the development of computer modelling tools for topics like system biology and physiologically based modelling, is a crucial part of this aim. A human cell and organoid-based in vitro technique is becoming increasingly popular for chemical toxicity assessment for a variety of factors including scientific relevance, effectiveness, affordability, and moral propriety.

Market Dynamics

Major players in the market are focused on the research and development activities, and thu,s it is expected to drive the market growth in near future. For instance, on June 21, 2021, a revised test guideline for the fish cell line acute toxicity assay was approved at the 33rd Meeting of the OECD Working Group of the National Coordinators, Austria for the Test Guidelines Programme in April 2021, and it had been published by the International Council on Animal Protection in OECD Programmes (ICAPO). Numerous studies have demonstrated how effectively the assay can forecast acute toxicity to fish for a wide range of chemicals when carried out in compliance with OECD test guidelines. Therefore, by including this assay into a weight of evidence or integrated approach to testing and assessment (IATA) for acute fish toxicity assessment, it has the potential to replace acute fish toxicity testing in a significant way.

Key features of the study

  • This report provides an in-depth analysis of the global in vitro toxicity testing market, and provides market size and compound annual growth rate for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global in vitro toxicity testing market based on the following parameters,company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Bio-Rad Laboratories, Inc., Cyprotex, Covance Inc., LifeNet Health LifeSciences , Creative Bioarray, Charles River Laboratories, Intertek Group plc, LGC Limited, SGS Societe Generale de Surveillance SA, Preferred Cell Systems, Microbac Laboratories, Inc., Eurofins Discovery, Creative Biolabs, LAUS GmbH, and Vimta Labs Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global in vitro toxicity testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in vitro toxicity testing market

Market Segmentation

  • Global In Vitro Toxicity Testing Market, By Type
    • Absorption
    • Toxic Substances
    • Dose
  • Global In Vitro Toxicity Testing Market, By End User
    • Cosmetics Industry
    • Pharmaceutical Industry
    • Food Industry
    • Chemicals Industry
  • Global In Vitro Toxicity Testing Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Global In Vitro Toxicity Testing Market - Key Players
    • Bio-Rad Laboratories, Inc.
    • Cyprotex
    • Covance Inc.
    • LifeNet Health LifeSciences
    • Creative Bioarray
    • Charles River Laboratories
    • Intertek Group plc
    • LGC Limited
    • SGS Societe Generale de Surveillance SA
    • Preferred Cell Systems
    • Microbac Laboratories, Inc.
    • Eurofins Discovery
    • Creative Biolabs
    • LAUS GmbH
    • Vimta Labs Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global In Vitro Toxicity Testing Market, By Type, 2020-2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Absorption
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Toxic Substances
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Dose
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global In Vitro Toxicity Testing Market, By End User, 2020-2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Cosmetics Industry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pharmaceutical Industry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Food Industry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Chemicals Industry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global In Vitro Toxicity Testing Market, By Region, 2020-2032, (USD Bn)

  • Overview
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User,2020- 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country ,2020- 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Bio-Rad Laboratories, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cyprotex
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Covance Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LifeNet Health LifeSciences
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Creative Bioarray
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Charles River Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Intertek Group plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LGC Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • SGS Societe Generale de Surveillance SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Preferred Cell Systems
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Microbac Laboratories, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eurofins Discovery
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Creative Biolabs
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LAUS GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Vimta Labs Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

8. Section

  • Research Methodology
  • About Us